|
Pharmocopia Medicine |
| ||||||||
 |
||||||||||
 |
||||||||||
| U4 Flupentixol 0.5mg & Melitracen 10mg | ||||||||||
 |
||||||||||
Depression and Anxiety can strike anyone.Anxiety is a frequenty problem for depressed patients and more
than 95% of all depressed patients suffer from anxiety. Conversely, it is likely that 20-65% of patients suffering from anxiety are also depressed. According to WHO Depression accounts for the loss of an average of 4 years of active life for every person in the world. The incidence and the prevalence of depression both rise markedly in those aged over 55 years: -It is the most common psychiatric mood disorder of old age -About 15% of those aged over 65 years old are clinically depressed at any one time. This compares with a population lifetime prevalence of 5-10%. Also An estimated 340 million people around the world suffer from the disease. Tt is estimated that, at any given time, 1.9% of all men and 3.2% of all women suffer from a depressive disorder for which they require treatment. There are many physical and social factors |
||||||||||
| - Stress, tension, fear etc - Psychoneurosis - Menopause - Dysmenorrhea |
- GL disturbances without organic findings - Chronic pain e.g. arthritis,spondylosis,headacge etc. - Alcoholism and drug addiction - Asthenia without any cause |
|||||||||
| Effetive in MADD | ||||||||||
| No of patients Disease Trial type Results |
:80%
of both sexes, age ranging from 18 to 60 year :Mixed Anxiety and Depressive Disorders (MADD) :Comparison between (Flupentixol + Melitracen) Vs Alprazolam :(Flupentixol + Melitracen) U4 was effective in MADD & superior to Alprazolams |
|||||||||
Address: No.59(b), Yaw Min Gyi St., Dagon Tsp., Yangon, Myanmar.
Tel / Fax : -95-1-243 627 / 95-1-374 714.
E-mail : speed@mail4u.com.mm,info@myanmarhealth.com